AI Business, Policy, and Drones: Raion Sovereign AI Forum 2025
AI Business, Policy, and Drones: Raion Sovereign AI Forum 2025 explores U.S.-EU AI tensions, drone warfare, and misinformation challenges shaping the future.
-
-
Prompt Engineering vs. Context Engineering: Crafting AI for Precision
Struggling to optimize AI interactions? Discover how Prompt Engineering vs. Context Engineering work together to craft precise, task-specific outcomes.
-
New Model Alert: Drainpipe Now Supports OpenAI GPT-4.1, GPT-4.1 Mini, GPT-4.1 Nano
Drainpipe now supports OpenAI GPT-4.1, GPT-4.1 Mini, and GPT-4.1 Nano models, offering enhanced performance and cost-effective AI solutions for users.
-
The Reality of AI Hallucinations in 2025
The Reality of AI Hallucinations in 2025 reveals why even top-tier models still generate false information 0.7% to 30% of the time, threatening business decisions.
-
New Model Alert: Drainpipe Now Supports Anthropic Claude 4 Opus and Claude 4 Sonnet
Drainpipe now supports Anthropic Claude 4 Opus and Claude 4 Sonnet, offering advanced coding capabilities and improved reasoning for complex AI tasks.
-
Drainpipe CEO Speaks at MGE 2025
Drainpipe CEO Dominick Romano spoke at MGE 2025 about gaming’s impact on youth culture and the future of interactive entertainment in Morocco.
-
To MCP or Not to MCP – That is the Question
MCP promises to streamline Enterprise AI integrations but serious security vulnerabilities raise critical questions about implementation safety.
-
May 2025 – Drainpipe Report on the State of AI Trustworthiness
AI trust is plummeting globally amid rising concerns over misinformation and job displacement. May 2025 Drainpipe Report reveals critical gaps.
-
Drainpipe CEO – Panel Speaker at Big Data & AI World
Drainpipe CEO Dominick Romano joins industry experts to discuss EU AI Act compliance challenges and opportunities at Big Data & AI World Frankfurt 2025.
-
Drainpipe CEO – Keynote Speaker at CPHI Americas 2025
Drainpipe CEO Dominick Romano keynotes at CPHI Americas 2025, addressing how US pharmaceutical companies must embrace AI to lead tomorrow’s market.
